HUTCHMED (China) Ltd
HCM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001648257
No open-market purchases or sales by HUTCHMED (China) Ltd insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $46.5M in total; no superinvestor holds it.
Other share classesHMDCF
Q3 2024 vs. Q2 2024
How the institutions holding HUTCHMED (China) Ltd changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 67 | 1 | 66 | 0 |
| Shares | 8.78M | 17.7K | 7.29M | −1.47M (−16.7%) |
| Value | $150.3M | $302.8K | $141.4M | −$8.67M (−5.8%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held HUTCHMED (China) Ltd at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Point72 Hong Kong Ltd | 21,562 | $421.1K | 0.03% |
| BlackRock, Inc. | 18,141 | $354.3K | 0.00% |
| Crossmark Global Holdings, Inc. | 16,792 | $328.0K | 0.01% |
| Summit Trail Advisors, LLC | 11,443 | $223.5K | 0.01% |
| Vident Advisory, LLC | 11,006 | $214.9K | 0.01% |
| Public Employees Retirement System of Ohio | 1,811 | $35.4K | 0.00% |
| Barclays PLC | 152 | $2.97K | 0.00% |
| Principal Securities, Inc. | 7 | $137 | 0.00% |
Sold out (8)
Institutions that held HUTCHMED (China) Ltd at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Long Corridor Asset Management Ltd | 49,049 | $839.7K |
| Trexquant Investment LP | 27,079 | $463.6K |
| Point72 Asset Management, L.P. | 16,300 | $279.1K |
| Cubist Systematic Strategies, LLC | 12,430 | $212.8K |
| Barometer Capital Management Inc. | 10,900 | $186.6K |
| Qube Research & Technologies Ltd | 1,925 | $33.0K |
| Aquatic Capital Management LLC | 1,700 | $29.1K |
| Wells Fargo & Company | 12 | $205 |
Not filed for Q3 2024 yet (1)
Institutions that held HUTCHMED (China) Ltd at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 17,684 | $302.8K |